CoChat

Head-to-Tail Cyclization after Interaction with Trypsin: A Scorpion Venom Peptide that Resembles Plant Cyclotides

Mourão, Caroline B. F., Brand, Guilherme D., Fernandes, João Paulo C., Prates, Maura V., Bloch, Carlos, Barbosa, João Alexandre R. G., Freitas, Sônia M., Restano-Cassulini, Rita, Possani, Lourival D., Schwartz, Elisabeth F. · 2020 · Journal of Medicinal Chemistry
Cited by 22

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Peptidase inhibitors (PIs) have been broadly studied due to their wide therapeutic potential for human diseases. A potent trypsin inhibitor from Tityus obscurus scorpion venom was characterized and named ToPI1, with 33 amino acid residues and three disulfide bonds. The X-ray structure of the ToPI1:trypsin complex, in association with the mass spectrometry data, indicate a sequential set of events: the complex formation with the inhibitor Lys 32 in the trypsin S1 pocket, the inhibitor C-terminal residue Ser 33 cleavage, and the cyclization of ToPI1 via a peptide bond between residues Ile 1 and Lys 32 . Kinetic and thermodynamic characterization of the complex was obtained. ToPI1 shares no sequence similarity with other PIs characterized to date and is the first PI with CS-α/β motif described from animal venoms. In its cyclic form, it shares structural similarities with plant cyclotides that also inhibit trypsin. These results bring new insights for studies with venom compounds, PIs, and drug design.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.0c00686

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 22

Metadata

Authors
Mourão, C. B. F., Brand, G. D., Fernandes, J. P. C., Prates, M. V., Bloch, C., Barbosa, J. A. R. G., Freitas, S. M., Restano-Cassulini, R., Possani, L. D., & Schwartz, E. F.
Venue
Journal of Medicinal Chemistry
Published
2020-07-31
Volume
63
Issue
17
Pages
9500-9511
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W3046393216
Cited by
22
References
1
FWCI
1.18
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.